These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 11232676

  • 1. Do some patients with Helicobacter pylori infection benefit from an extension to 2 weeks of a proton pump inhibitor-based triple eradication therapy?
    Maconi G, Parente F, Russo A, Vago L, Imbesi V, Bianchi Porro G.
    Am J Gastroenterol; 2001 Feb; 96(2):359-66. PubMed ID: 11232676
    [Abstract] [Full Text] [Related]

  • 2. 2-week triple therapy for Helicobacter pylori infection is better than 1-week in clinical practice: a large prospective single-center randomized study.
    Paoluzi P, Iacopini F, Crispino P, Nardi F, Bella A, Rivera M, Rossi P, Gurnari M, Caracciolo F, Zippi M, Pica R.
    Helicobacter; 2006 Dec; 11(6):562-8. PubMed ID: 17083378
    [Abstract] [Full Text] [Related]

  • 3. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
    Schwartz H, Krause R, Sahba B, Haber M, Weissfeld A, Rose P, Siepman N, Freston J.
    Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of metronidazole for the treatment of clarithromycin-resistant Helicobacter pylori infection in a Japanese population.
    Shimoyama T, Fukuda S, Mikami T, Fukushi M, Munakata A.
    J Gastroenterol; 2004 Oct; 39(10):927-30. PubMed ID: 15549444
    [Abstract] [Full Text] [Related]

  • 5. Comparison of 7-day and 14-day proton pump inhibitor-containing triple therapy for Helicobacter pylori eradication: neither treatment duration provides acceptable eradication rate in Korea.
    Kim BG, Lee DH, Ye BD, Lee KH, Kim BW, Kim SG, Kim SW, Kim SK, Kim JJ, Kim HY, Park JJ, Park CY, Baik GH, Lee YC, Lee JH, Lee JH, Chun HJ, Hahm KB, Hong SJ, Lee SW, Jung HC.
    Helicobacter; 2007 Feb; 12(1):31-5. PubMed ID: 17241298
    [Abstract] [Full Text] [Related]

  • 6. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
    Güliter S, Keleş H, Ozkurt ZN, Cengiz DU, Kolukisa E.
    Turk J Gastroenterol; 2005 Mar; 16(1):29-33. PubMed ID: 16252185
    [Abstract] [Full Text] [Related]

  • 7. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
    Avidan B, Melzer E, Keller N, Bar-Meir S.
    Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370
    [Abstract] [Full Text] [Related]

  • 8. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
    Köksal AS, Parlak E, Filik L, Yolcu OF, Odemiş B, Ulker A, Saşmaz N, Ozden A, Sahin B.
    J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716
    [Abstract] [Full Text] [Related]

  • 9. Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection.
    Murakami K, Okimoto T, Kodama M, Sato R, Miyajima H, Ono M, Inoue K, Watanabe K, Otsu S, Fujioka T.
    Helicobacter; 2006 Oct; 11(5):436-40. PubMed ID: 16961805
    [Abstract] [Full Text] [Related]

  • 10. Second-line treatment for Helicobacter pylori infection in Japan: proton pump inhibitor-based amoxicillin and metronidazole regimen.
    Nagahara A, Miwa H, Kawabe M, Kurosawa A, Asaoka D, Hojo M, Iijima K, Terai T, Ohkusa T, Miyazaki A, Sato N.
    J Gastroenterol; 2004 Nov; 39(11):1051-5. PubMed ID: 15580397
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of metronidazole as second-line drug for the treatment of Helicobacter pylori Infection in the Japanese population: a multicenter study in the Tokyo Metropolitan Area.
    Matsuhisa T, Kawai T, Masaoka T, Suzuki H, Ito M, Kawamura Y, Tokunaga K, Suzuki M, Mine T, Takahashi S, Sakaki N.
    Helicobacter; 2006 Jun; 11(3):152-8. PubMed ID: 16684262
    [Abstract] [Full Text] [Related]

  • 12. A four-day low dose triple therapy regimen for the treatment of Helicobacter pylori infection.
    Trevisani L, Sartori S, Caselli M, Ruina M, Verdianelli G, Abbasciano V.
    Am J Gastroenterol; 1998 Mar; 93(3):390-3. PubMed ID: 9517646
    [Abstract] [Full Text] [Related]

  • 13. Eradication of Helicobacter pylori infection with proton pump inhibitor-based triple therapy. A randomised study.
    Palmas F, Pellicano R, Massimetti E, Berrutti M, Fagoonee S, Rizzetto M.
    Panminerva Med; 2002 Jun; 44(2):145-7. PubMed ID: 12032434
    [Abstract] [Full Text] [Related]

  • 14. The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication.
    Wheeldon TU, Granström M, Hoang TT, Phuncarg DC, Nilsson LE, Sörberg M.
    Aliment Pharmacol Ther; 2004 Jun 15; 19(12):1315-21. PubMed ID: 15191514
    [Abstract] [Full Text] [Related]

  • 15. Comparison of 1-week and 2-week triple therapy with omeprazole, amoxicillin, and clarithromycin in peptic ulcer patients with Helicobacter pylori infection: results of a randomized controlled trial.
    Kiyota K, Habu Y, Sugano Y, Inokuchi H, Mizuno S, Kimoto K, Kawai K.
    J Gastroenterol; 1999 Jun 15; 34 Suppl 11():76-9. PubMed ID: 10616771
    [Abstract] [Full Text] [Related]

  • 16. Relationship between the results of pre-treatment urea breath test and efficacy of eradication of Helicobacter pylori infection.
    Perri F, Clemente R, Festa V, Quitadamo M, Conoscitore P, Niro G, Ghoos Y, Rutgeerts P, Andriulli A.
    Ital J Gastroenterol Hepatol; 1998 Apr 15; 30(2):146-50. PubMed ID: 9675647
    [Abstract] [Full Text] [Related]

  • 17. Lafutidine versus lansoprazole in combination with clarithromycin and amoxicillin for one versus two weeks for Helicobacter pylori eradication in Korea.
    Kim N, Park SH, Seo GS, Lee SW, Kim JW, Lee KJ, Shin WC, Kim TN, Park MI, Park JJ, Hong SJ, Shim KN, Kim SW, Shin YW, Chang YW, Chun HJ, Lee OJ, Jeon WJ, Park CG, Cho CM, Park CH, Won SY, Lee GH, Park KS, Shin JE, Kim HU, Park JY, Chae HS, Song GA, Kim JG, Yoon BC, Seol S, Jung HC, Chung IS.
    Helicobacter; 2008 Dec 15; 13(6):542-9. PubMed ID: 19166420
    [Abstract] [Full Text] [Related]

  • 18. Dose-dependent inhibition of CYP3A activity by clarithromycin during Helicobacter pylori eradication therapy assessed by changes in plasma lansoprazole levels and partial cortisol clearance to 6beta-hydroxycortisol.
    Ushiama H, Echizen H, Nachi S, Ohnishi A.
    Clin Pharmacol Ther; 2002 Jul 15; 72(1):33-43. PubMed ID: 12152002
    [Abstract] [Full Text] [Related]

  • 19. [Treatment of Helicobacter pylori infection with lansoprazole 30 mg or 60 mg combined with two antibiotics for duodenal ulcers].
    Lamouliatte H, Perie F, Joubert-Collin M.
    Gastroenterol Clin Biol; 2000 May 15; 24(5):495-500. PubMed ID: 10891736
    [Abstract] [Full Text] [Related]

  • 20. Comparison of azithromycin and clarithromycin in triple therapy regimens for the eradication of Helicobacter pylori.
    Sullivan B, Coyle W, Nemec R, Dunteman T.
    Am J Gastroenterol; 2002 Oct 15; 97(10):2536-9. PubMed ID: 12385435
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.